Research and Development
Research in Apotex® includes the development of generic, biosimilar and innovative pharmaceutical products.
The new products have been a critical component of our growth and have led to our expertise in the development of formulations, synthesis of active ingredients and chemical analysis.
We have invested more than 1 trillion Canadian dollars in the last ten years to develop innovative product solutions in several categories, with a forecast to double that investment in the next ten years. We are part of the Top 100 of Canadian companies investing in Research and Development.